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Objective. This study aimed to examine atypical and malignant papillary oral lesions for low- and high-risk human
papillomavirus (HPV) infection and to correlate HPV infection with clinical and pathologic features.
Study Design. Sections of 28 atypical papillary lesions (APLs) and 14 malignant papillary lesions (MPLs) were examined for
HPV by in situ hybridization and for p16 and MIB-1 by immunohistochemistry; 24 conventional papillomas were studied for
comparison.
Results. Low-risk HPV was found in 10 of 66 cases, including 9 APLs and 1 papilloma. All low-risk HPVepositive cases
showed suprabasilar MIB-1 staining, and the agreement was statistically significant (P < .0001). Diffuse p16 staining
combined with high-risk HPV was not seen in any of the cases. A subset of HPV APLs progressed to carcinoma.
Conclusions. Oral papillary lesions are a heterogeneous group. Low-risk HPV infection is associated with a subset of APLs
with a benign clinical course. Potentially malignant APLs and MPLs are not associated with low- or high-risk HPV. (Oral Surg
Oral Med Oral Pathol Oral Radiol 2014;117:722-732)Papillary lesions of the oral mucosa present with a range
of clinical and histologic appearances, from benign
to malignant. Squamous papilloma is a common and
benign lesion that is clinically well-demarcated, round or
oval in shape, and generally less than 1 cm in diameter.
Recurrence is rare after conservative excision. Histo-
logically, the papillary projections are covered by acan-
thotic stratiﬁed squamous epithelium with a normal
pattern of maturation and occasionally basilar hyperpla-
sia.1 Less frequently, there are lesions that architecturally
resemble a papilloma, but with atypical clinical or his-
tologic features. Atypical clinical features include larger
size, irregular outline, progressive growth, and recur-
rence. Atypical histologic features include variably sha-
ped rete ridges and dysplasia of the epithelium that
covers the papillary projections. Exophytic, papillaryThe authors acknowledge the support of Ventana Medical Systems in
making the Inform HPV II and III probes available through collabo-
ration with Dr M.S. Tsao at the University Health Network. Grant
support was provided by the Dental Research Institute, Faculty of
Dentistry, University of Toronto.
aFaculty of Dentistry, University of Toronto.
bApplied Molecular Proﬁling Laboratory, Ontario Cancer Institute,
University of Toronto.
cDepartment of Biostatistics, University Health Network.
dDepartment of Surgical Oncology/OtolaryngologyeHead and Neck
Surgery, Princess Margaret Cancer Centre, University of Toronto.
eDepartment of Pathology and Laboratory Medicine, Mount Sinai
Hospital.
fDepartment of Pathology, University Health Network.
gOntario Cancer Institute, University Health Network, University of
Toronto.
Received for publication Oct 9, 2013; returned for revision Jan 30,
2014; accepted for publication Feb 4, 2014.
 2014 Elsevier Inc.
2212-4403
http://dx.doi.org/10.1016/j.oooo.2014.02.003
722
Open access under CC BY-NC-ND license.epithelial proliferations with dysplasia, referred to as
dysplastic oral warts, have been described in HIVþ pa-
tients.2-4 However, atypical papillary lesions (APLs) of
the oral mucosa in immunocompetent persons have not
been well documented with respect to diagnostic criteria
and biologic potential.
The nomenclature of malignant papillary lesions
(MPLs) is controversial, and the term may include
papillary carcinoma, papillary squamous cell carci-
noma, and exophytic squamous cell carcinoma.5-10
Papillary carcinomas and papillary squamous cell car-
cinoma have both been deﬁned as exophytic, papillary
neoplasms in which the epithelium covering the surface
projections shows either carcinoma in situ or pro-
nounced cellular pleomorphism with keratinization at
the surface.5,6,11 Other authors have characterized the
epithelium of papillary squamous cell carcinoma as
high-grade dysplasia with no surface keratinization.8
Exophytic squamous cell carcinoma has histologic fea-
tures that overlap with papillary squamous cell carci-
noma, but the surface projections are broad-based and
bulbous rather than ﬁnger-like.9 There seems to beStatement of Clinical Relevance
Oral papillary lesions are a heterogeneous group
with variable clinical behavior. Preliminary evi-
dence suggests that low-risk human papillomavirus
(HPV)epositive atypical papillary lesions run a
benign clinical course. Potentially malignant and
malignant papillary lesions are not associated with
HPV infection.
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plasms is usually superﬁcial and may be difﬁcult to
conﬁrm unequivocally, and the diagnosis of carcinoma
may be made on the basis of the extent of growth of
the exophytic mass even in the absence of deﬁnitive
stromal invasion.8-10 These lesions are considered
distinct on one hand from conventional squamous cell
carcinoma with both exophytic and endophytic inva-
sive components, and on the other hand from verru-
cous carcinoma. They are distinguished from the
former by a wholly exophytic papillary architecture
of the carcinoma and from the latter by signiﬁcant
dysplasia and inﬁltrative islands rather than blunt,
pushing invasion.8-10
Human papillomavirus (HPV) has been shown to
cause a variety of papillary lesions of skin and mucosa,
including verruca vulgaris, condyloma acuminatum,
focal epithelial hyperplasia, and recurrent respiratory
papillomatosis.12 Previous studies have examined
benign, atypical, and malignant oral papillary lesions
for the presence of HPV using a variety of methods,
including immunohistochemical staining for HPV
common antigen, in situ hybridization (ISH) with DNA
probes, polymerase chain reaction (PCR), and in situ
reverse transcriptase PCR.13-21 The reported prevalence
of HPV in oral squamous papilloma varies from 13%
to 68%, and all positive cases are low-risk HPV types
6 and 11.15,18,21 HPV is more commonly detected in
oral condyloma acuminatum, but there is considerable
overlap in the histopathologic features of condyloma
and papilloma of the oral mucosa.16,22 There is a strong
association between HPV and oral exophytic epithelial
lesions in immunosuppressed patients.4,13,19 The pre-
valence of HPV in malignant oral verrucous or papil-
lary lesions in immunocompetent patients is much
lower.14,17,20
This study examined a group of atypical and malig-
nant papillary lesions for low- and high-risk HPV and
correlated the detection of HPV with clinical and
pathologic features, with the aim of improving our
understanding of these uncommon oral lesions.
MATERIALS AND METHODS
This was a retrospective study of biopsy specimens of
oral mucosal lesions submitted to the Oral Pathology
Diagnostic Service (OPDS) at the Faculty of Dentistry,
University of Toronto, by general and specialist dentists
in the province of Ontario, Canada. This study was
approved by the Research Ethics Boards of the Uni-
versity of Toronto (protocol 26571) and the University
Health Network (UHN) (protocol 12-5269-TE). A
search of the OPDS ﬁles from 2005 to 2011 was con-
ducted using the keyword “papillary.” A total of 28
APLs and 14 MPLs were identiﬁed. For comparison
with the APLs and MPLs, 24 cases of squamouspapilloma accessioned during the same period were also
collected for study. Lesions diagnosed as inﬂammatory
papillary hyperplasia of the palate were excluded from
the study, because this is well recognized as a reactive
mucosal condition. No patients included in the study
had a history of immunosuppression. Fourteen cases of
normal oral epithelium from specimens diagnosed as
ﬁbroepithelial polyp or amalgam tattoo, from a variety
of oral sites, were used as normal controls.
Clinical follow-up information on cases of APL and
MPL was obtained from the clinician who submitted
the biopsy. Some of the patients with a persistent lesion
after biopsy were referred to the Department of Head
and Neck Surgery at the Princess Margaret Cancer
Centre, UHN, for further treatment. Follow-up infor-
mation for these patients was obtained by chart review
at UHN.In situ DNA hybridization for high- and low-risk
HPV
In situ hybridization (ISH) for HPV DNA was performed
on 4-mm-thick sections of formalin-ﬁxed, parafﬁn-
embedded (FFPE) biopsy specimens, using the Inform
HPV II Family 6 probe (B) for low-risk HPV and the
Inform HPV III Family 16 probe (B) for high-risk HPV
on a Ventana Benchmark automated slide stainer ac-
cording to the manufacturer’s instructions (Ventana
Medical Systems Inc, Tucson, AZ, USA), as previously
described.23 The Family 6 probe detected low-risk HPV
types 6 and 11. The Family 16 probe detected high-risk
HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and
66. A case of condyloma acuminatum was used as the
positive control for the Family 6 probe and normal oral
epithelium was used as the negative staining control. For
the Family 16 probe, high-risk HPV 3-in-1 control slides
supplied by the manufacturer were used, including CaSki
cells (HPV16þ, 200-600 copies per cell), HeLa cells
(HPV18þ, 10-50 copies per cell), and T24 cells (HPV).
In addition, a case of HPV16þ oropharyngeal carcinoma
was used as positive control for the Family 16 probe.
ISH for HPV DNA was scored as positive when blue
reaction product was seen in the nucleus of lesional cells,
in either a homogeneous or punctate pattern. Staining
that was not localized to the nucleus of epithelial cells
was interpreted as background staining. Positive and
negative controls were included in each run of ISH, and
the expected results were obtained. All cases were scored
independently by 2 observers (C.M. and G.B.) following
the aforementioned criteria, and there was no disagree-
ment between observers.Immunohistochemical staining
Immunohistochemical staining for p16 protein (cyclin-
dependent kinase inhibitor 2A, CDKN2A) was performed
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antibody to p16 (CINtec; Roche mtm laboratories,
Westborough,MA, USA) and a Ventana Benchmark XT
automated slide stainer, according to the manufacturer’s
instructions (Ventana Medical Systems Inc), as previ-
ously described.23 Sections were incubated with pre-
diluted, ready-to-use antibody to p16 for 32 minutes at
37C. A case of HPVþ oropharyngeal carcinoma was
used as the positive staining control. Cases of normal
oral epithelium were used as negative staining controls.
Staining for p16 protein was seen in both nucleus and
cytoplasm of epithelial cells, in agreement with previous
reports.24,25 The grading of p16 staining was in accor-
dance with a previously described protocol.23 Brieﬂy,
p16 staining was scored as positive when there was
strong, diffuse staining of lesional epithelium. Staining
was scored as equivocal when there was patchy staining
with unstained epithelial cells interspersed among cells
with nuclear and cytoplasmic staining. Cases with no
staining or staining of scattered, single cells within the
lesion were scored as negative. Positive and negative
controls were included in each staining run, and the
expected results were obtained. All cases were scored
independently by 2 observers (C.M. and G.B.). There
were a few cases for which the observers’ scores varied
between equivocal and negative, and the disagreements
were resolved by discussion.
Immunohistochemical staining for Ki-67 antigen
was performed using the monoclonal antibody MIB-1
(Dako Canada, Burlington, Ontario, Canada) and a
Ventana Benchmark XT automated slide stainer, ac-
cording to the manufacturer’s instructions (Ventana
Medical Systems Inc), as previously described.23 Sec-
tions were incubated with the MIB-1 antibody at 1:100
dilution for 60 minutes at 37C. Normal oral epithelium
was used as the control in each staining run, where a
subset of cells in the basal and parabasal layers showed
staining of the nucleus. Cases were scored in accor-
dance with a modiﬁcation of a previously described
protocol.23 This modiﬁcation of the previous protocol
was necessary because the range of MIB-1 staining
seen in the papillary lesions was less than that seen in
oral epithelial dysplasia in the previous study.23 Stain-
ing that was localized to basal and parabasal epithelial
nuclei was scored as grade 1. Staining of nuclei in
suprabasal layers in addition to basal and parabasal
layers was scored as grade 2.Statistical analysis
Descriptive statistics were provided as median and range
for continuous variables and as frequencies and pro-
portions for categorical variables. The utility of immu-
nohistochemical staining for Ki-67 and p16 as markers
for the presence of low-risk HPV was examined by a testfor agreement, and the kappa coefﬁcient (k) was calcu-
lated. The association between HPV infection status and
clinical variables was analyzed using the Fisher exact test
and the Wilcoxon rank sum test. Two-sided tests were
applied. Results were considered signiﬁcant at P < .05.
All the statistical analyses were performed with SAS 9.2
(SAS Institute Inc, Cary, NC, USA).
RESULTS
Clinical and pathologic findings
Included in this study were 28 APLs and 14 MPLs; 24
papillomas were also studied for comparison. The clin-
ical characteristics for the papillomas, APLs, and MPLs
are listed in Table I. The median age for the APL group
was 60 years, whereas the median age for theMPL group
was older at 76 years. Both groups showed a similar age
range. The median age for the papilloma group was 45
years (see Table I). The patients’ smoking history was
available for 16 of 28 APLs and 9 of 14 MPLs. Inter-
estingly, none of the 9 patients with MPL with known
smoking history was a current smoker, as 8 of 9 were
nonsmokers and one was a former light smoker (1-2
cigarettes per day). The most commonly affected site for
all groups of papillary lesions was the gingiva. Eight of
24 squamous papillomas, 9 of 28 APLs, and 7 of 14
MPLs were removed from the gingiva. The soft palate
was a relatively frequent site of involvement for papil-
lomas (4 cases) but was uncommon for APLs (with only
1 case occurring at this site). None of the MPLs were
seen in the soft palate (see Table I). The size of the le-
sions was determined from the clinical description in
cases of incisional biopsy or from the gross description
veriﬁed by on-slide measurement in cases of excisional
biopsy. The papillomas ranged from 0.25 to 1.0 cm,
whereas APLs ranged from 0.3 cm to 7.6 cm, and MPLs
ranged from 1 cm to greater than 5 cm.
All 24 cases of squamous papilloma showed the
classic features of this lesion, consisting of a narrow,
branching core of ﬁbrovascular connective tissue cov-
ered by stratiﬁed squamous epithelium with a normal
maturation pattern and no evidence of dysplasia1
(Figure 1, A, B). All except 1 case of APLs were
distinguished from papillomas by histologic ﬁndings.
The exception was a ﬂoor of mouth lesion described
clinically as atypical because of the irregular shape and
relatively large size. The other 27 APLs were exophytic
growths with papillary projections that were covered by
dysplastic epithelium, with no evidence of invasion into
the connective tissue stroma. The rete ridges were
widened and elongated, with epithelial dysplasia seen as
irregular maturation pattern and increased nuclear-to-
cytoplasmic ratio, nuclear hyperchromatism, and pleo-
morphism predominantly affecting the deep half of the
epithelium (see Figure 1, C-F). Of the 28 APLs, 25
showed a mild to moderate inﬂammatory inﬁltrate in the
Table I. Clinical features of papillary epithelial lesions
Variable Papillomas
Atypical
papillary lesions
Malignant
papillary lesions
Total sample 24 28 14
Age (y)
Median (range) 45 (7-81) 60 (32-95) 76 (46-93)
Sex
Male 13 17 6
Female 11 11 8
Smoking history*
Nonsmoker Not done 9 9
Smoker Not done 7 0
Unknown Not done 12 5
Site
Gingiva 33.3% (8/24) 32.1% (9/28) 50% (7/14)
Floor of mouth 16.7% (4/24) 14.3% (4/28) 21.4% (3/14)
Tongue 12.5% (3/24) 21.4% (6/28) 7.1% (1/14)
Hard palate, palate NOS 4.2% (1/24) 3.6% (1/28) 7.1% (1/14)
Soft palate 16.7% (4/24) 3.6% (1/28) 0%
Lip 8.3% (2/24) 14.3% (4/28) 0%
Buccal mucosa 8.3% (2/24) 10.7% (3/28) 14.3% (2/14)
NOS, not otherwise speciﬁed.
*Smoking history was not determined for papilloma cases.
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exocytosis into the epithelium (see Figure 1, E, F).
However, the epithelial abnormalities exhibited by the
APL group (including bulbous rete ridges, disturbed
maturation pattern, and nuclear hyperchromatism) were
greater than would be expected from reactive changes
to inﬂammation. Further, inﬂammatory exocytosis was
not limited to the APL group, with 20 of 24 papillomas
and 14 of 14 MPLs also demonstrating inﬂammatory
exocytosis.
The MPLs were similar to the APLs in that they also
presented as exophytic papillary lesions covered by
epithelium with dysplasia that involved the deep half
of the epithelial thickness or (less commonly) the
entire thickness. However, the MPLs differed from the
APLs by a greater degree of epithelial proliferation
and complex papillary architecture. Islands of invasive
carcinoma were seen in the superﬁcial aspect of the
connective tissue (see Figure 1, G, H) and were
distinguished from artifacts of tangential sectioning by
examination of multiple sections of the biopsy. The
extent of epithelial proliferation clinically and histo-
logically supported the diagnosis of malignancy in
cases where invasion was focal or superﬁcial. In this
study, we excluded cases of conventional squamous
cell carcinoma with limited areas of papillary surface
growth or with a rough surface due to multiple in-
vaginations of the malignant epithelium.
We examined all cases for the presence of koilocy-
tosis, which was observed as groups of upper spinous
cells with an irregularly shaped (raisin-like) nucleus and
clear cytoplasm. These histologic features have been
found to correlate with the presence of HPV in theepithelial cells.1 Koilocytosis was present in 50% of
papillomas (12 of 24), 43% of APLs (12 of 28), and
36% of MPLs (5 of 14).Immunohistochemical staining for p16 protein
Immunohistochemical staining for p16 was used as a
sensitive marker for infection by high-risk HPV and viral
oncoprotein expression.26,27 Previous reports have found
that strong, diffuse staining of lesional epithelium corre-
lated with detection of high-risk HPV by ISH.23,25,28
Expression of the E7 oncoprotein of high-risk HPV re-
sults in inactivation of Rb (retinoblastoma, RB1) and
overexpression of p16, which primarily functions as an
inhibitor of phosphorylation of Rb by cyclin D/cdk4 and
cyclin D/cdk6.29,30 Thus the ﬁnding of diffuse p16
staining in mucosal epithelium indicates infection by
high-risk HPV that is biologically signiﬁcant in that the
Rbecyclin D-cdk4/6ep16 pathway has been disrupted
by the E7 oncoprotein.27 Strong, diffuse staining for p16
was not observed in any of our cases in this study. A
patchy pattern of p16 staining (Figure 2), in which groups
of lesional cells with nuclear and cytoplasmic staining
were interspersed with cells with no staining, was found
in 20% of papillomas (2 of 10), 57.1% ofAPLs (16 of 28),
and 28.6% of MPLs (4 of 14) (Table II).In situ hybridization for HPV DNA
All cases included in the study were investigated for
low-risk HPV DNA with ISH. It was found that 10 of
66 cases, including 9 cases of APL and 1 of papilloma,
had evidence of low-risk HPV DNA. Evidence of
low-risk HPV was not found in any of the MPLs
Fig. 1. Hematoxylin-eosin-stained sections. A, Squamous papilloma (original magniﬁcation 1). B, Higher magniﬁcation of the
same lesion shown in A (10). C, HPV6þ/HPV11þ atypical papillary lesion (1). D, Higher magniﬁcation of the same lesion
shown in C (10). E, HPV atypical papillary lesion (0.8). F, Higher magniﬁcation of the same lesion shown in E (10).
G, Malignant papillary lesion with arrowhead showing invasion depicted in H (0.5). H, Higher magniﬁcation of the same lesion
shown in G (10). (HPV, human papillomavirus.)
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neous hybridization signal within the nuclei of lesional
cells (Figure 3), consistent with the presence of
episomal viral DNA. A punctate pattern of hybridiza-
tion, suggestive of integrated viral DNA, was not seenin any of the positive cases. Groups of labeled nuclei
were restricted to the superﬁcial aspect of the lesional
epithelium and were not present in the basal or para-
basal layers of the papillary proliferation or in the
adjacent unaffected mucosa.
Table II. Results of analyses for p16, low-risk and high-risk HPV, and MIB-1
Lesion
p16 patchy
staining
Low-risk
HPVepositive
High-risk
HPVepositive
MIB-1 basal/
parabasal
MIB-1
suprabasal
Papillomas (n ¼ 24) 20.0% (2/10)* 4.2% (1/24) Not done 90% (9/10)* 10% (1/10)*
Atypical papillary lesions (n ¼ 28) 57.1% (16/28) 32.1% (9/28) 0% (0/16) 60.7% (17/28) 39.3% (11/28)
Malignant papillary lesions (n ¼ 14) 28.6% (4/14) 0% (0/14) 0% (0/4)y 93% (13/14) 7% (1/14)
HPV, human papillomavirus.
*10 of 24 papillomas were stained for p16 and MIB-1.
yISH for high-risk HPV was done for atypical and malignant papillary lesions with p16 staining; it was not done for lesions with no p16 staining.
Fig. 2. Patchy staining for p16. A, HPV malignant papillary lesion (original magniﬁcation 25). B, Higher magniﬁcation of the
same lesion shown in A (200). C, HPV6þ/HPV11þ atypical papillary lesion (25). D, Higher magniﬁcation of the same lesion
shown in C (200). (HPV, human papillomavirus.)
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in a subset of APLs and MPLs was indicative of high-
risk HPV infection, all cases showing patchy p16
staining were examined for high-risk HPV DNA (see
Table II). None of the lesions showed evidence of high-
risk HPV DNA by ISH, indicating that the patchy p16
staining pattern was not associated with the presence of
high-risk HPV.23Immunohistochemical staining for MIB-1
Immunohistochemical staining for MIB-1 was used to
indicate the distribution of proliferative cells within the
epithelium. In the stratiﬁed squamous epithelium adja-
cent to the papillary lesions, proliferative cells were
restricted to the basal and parabasal layers. A similar
pattern of MIB-1 staining was seen in HPV squamous
papillomas (Figure 4, A, B). In 17 of 19 HPV APLs,
MIB-1 staining was localized to the basal and parabasal
layers with a few scattered positive suprabasal nuclei,
which corresponded to the histopathologic ﬁnding ofmild to moderate dysplasia in APLs (see Figure 4, C, D).
In contrast, all 10 of the papillary lesions (1 squamous
papilloma and 9 APLs) that were positive for low-risk
HPV by ISH showed MIB-1 positive nuclei dispersed
throughout the epithelial layers rather than localized to
the basal and parabasal layers (see Figure 4, E, F).
Similar MIB-1 staining of suprabasal nuclei was also
seen in 2 cases of APL and 1 case of MPL that were
negative for low-risk HPV (see Table II). In the other 13
of 14 MPL cases, MIB-1þ nuclei were in a basal and
parabasal distribution, consistent with the predominantly
well-differentiated histomorphology of these lesions.Immunohistochemical markers for presence of
low-risk HPV
The results of MIB-1 and p16 staining were compared
with those of ISH for low-risk HPV to determine if one
or both immunohistochemical assays could be used
as an indirect test for low-risk HPV in oral papillary
lesions. For the 52 cases of papilloma, APL, or MPL for
Fig. 3. In situ hybridization for HPV6 and HPV11. A, B, An atypical papillary lesion with a homogeneous hybridization signal in
lesional nuclei (original magniﬁcation 50 and 200, respectively). C, D, Another atypical papillary lesion showing a similar
hybridization pattern (50 and 200, respectively). (HPV, human papillomavirus.)
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staining with ISH for low-risk HPV was assessed, and
similarly for p16 staining vs ISH for low-risk HPV
(Table III). There was strong agreement between
suprabasal MIB-1 staining and detection of low-risk
HPV (k ¼ 0.83). There was less agreement between
patchy p16 staining and detection of low-risk HPV
(k ¼ 0.41), because 13 of 42 cases that were HPV also
showed patchy p16 staining (see Table III).Clinical features and outcome of APL cases
The clinical parameters of low-risk HPVepositive and
enegative cases of APL were compared (Table IV).
There was a predominance of men among the HPVþ
cases (male-to-female ratio, 8:1) that was not present
in the HPV cases (P ¼ .05; Fisher exact test). The
HPVþ APL group had a younger median age and a
higher proportion of smokers, but the differences were
not statistically signiﬁcant.
Clinical follow-up information was obtained for 17 of
the 28 patients with APL. Although the follow-up data
were limited, a difference was seen between the low-risk
HPVepositive cases and the HPV cases (see Table IV).
Among 9 patients with HPVþ lesions, follow-up was
obtained for 6; 4 of the 6 had no recurrence after excision
of the lesion, with a follow-up period of 5 to 18 months
(median, 10 months). One patient had 5 recurrences at
the same site over 50 months, with no increase in extent
of the papillary lesion. The sixth patient developed a
recurrent 2-mm lesion at 9 months, which was excisedwith no further recurrence. None of the HPVþ cases
developed into oral carcinoma.
Among 19 patients with HPV lesions, follow-up
was obtained for 11; 6 of the 11 had no recurrence after
excision of the lesion, with a follow-up period of 4 to 46
months (median, 28 months). One patient had a recur-
rent lesion at 21 months, which was again excised. For
another patient in this group, an 86-year-old woman, the
submitted specimen was an incisional biopsy of a large,
papillary mucosal lesion. No deﬁnitive treatment was
provided, owing to poor health. Three patients had
recurrent or persistent lesions that progressed to carci-
noma of the gingiva, lateral tongue, and buccal mucosa,
respectively (see Table IV).Clinical outcome of MPL cases
Clinical follow-up was available for 10 of the 14 pa-
tients with MPL. One patient died of unrelated causes
54 months after biopsy of the oral lesion. Nine patients
were referred to the Head and Neck Oncology Clinic
for treatment, which consisted of surgical resection,
radiation therapy, or both. Of these 9 patients, 7 were
alive without disease at last follow-up, which varied
from 34 months to 71 months (median, 43 months).
One patient with a buccal mucosal lesion was treated
with primary radiation therapy; recurrence at 8 months
was treated with surgery. She then developed a second
primary carcinoma at 17 months and was treated with
palliative care only. The 10th patient, an 85-year-old
woman, did not undergo deﬁnitive treatment, owing to
Fig. 4. MIB-1 immunohistochemistry. A, Staining of basal and parabasal nuclei in a squamous papilloma (original
magniﬁcation 12.5). B, Case A at higher magniﬁcation (50). C, Staining of basal and parabasal nuclei with occasional scattered
positive suprabasal nuclei in an HPV atypical papillary lesion (12.5). D, Case C at higher magniﬁcation (50). E, Staining of
basal, parabasal, and suprabasal nuclei in a HPV6þ/HPV11þ atypical papillary lesion (12.5). F, Case E at higher magniﬁcation
(50). (HPV, human papillomavirus.)
Table III. Test for agreement of MIB-1 with low-risk
HPV and p16 with low-risk HPV
HPV HPVþ k (95% CI) P
MIB-1 staining
Basal and parabasal 39 0 0.83 (0.65-1) < .0001
Suprabasal 3 10
p16 staining
None 29 1 0.41 (0.18-0.63) .0007
Patchy 13 9
HPV, human papillomavirus.
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follow-up. None of the patients with follow-up has died
of the MPL.DISCUSSION
The association between HPV and the spectrum of oral
papillary epithelial proliferations has not been clearlyestablished. The variation in ﬁndings reported in the
literature may be due to case selection, inclusion of
immunocompromised patients, and use of different
techniques for HPV detection. We used a combination
of clinical data, histopathologic examination, and ISH
to demonstrate an association between low-risk HPV
and a subset of APLs that ran a benign course, although
the duration of follow-up was relatively short and
follow-up was not available for 3 of the 9 patients
with low-risk HPVþ APLs. None of the lesions had
detectable high-risk HPV. Some of the HPV APLs
had persistent growth and progression to carcinoma.
Follow-up was obtained for 11 of 19 patients with
HPV APLs, so it is possible that there were more
patients in this group who progressed to carcinoma.
HPV was not detected in any of the MPLs. Thus, our
ﬁndings suggest that potentially malignant and malig-
nant papillary oral lesions are not associated with low-
or high-risk HPV. The number of APLs and MPLs in
Table IV. Clinical parameters and follow-up informa-
tion for atypical papillary lesion cases
HPV6þ (n ¼ 9) HPV6 (n ¼ 19) P
Age (y)
Median (range) 53 (32-82) 76 (46-95) .10*
Sex
Male 8 9 .05y
Female 1 10
Smoking status
Smoker 5 4 .36y
Nonsmoker 2 5
Unknown 2 10
Follow-up
No recurrence 4 6
Recurred/persisted 2 2
Progressed 0 3
Unknown 3 8
HPV, human papillomavirus.
*Wilcoxon test.
yFisher exact test.
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be conﬁrmed in further studies of biologically signiﬁ-
cant HPV infection in these uncommon oral papillary
lesions.
In our study, 10 of the 66 oral papillary lesions
showed low-risk HPV by ISH. One of 24 papillomas
was HPVþ, and this was the largest lesion within the
papilloma group. HPV was detected in 9 of 28 APLs,
which are papillary lesions distinguished from simple
squamous papillomas by a combination of larger size,
irregular shape, and epithelial dysplasia, seen as irreg-
ular maturation pattern with nuclear hyperchromatism
and increased nuclear-to-cytoplasmic ratio in the deep
half of the epithelium. All cases that were low-risk
HPVepositive showed MIB-1þ nuclei in the suprabasal
epithelium and loss of localization of MIB-1 staining to
basal and parabasal epithelial cells that constitute the
normal proliferative compartment (see Table II). These
ﬁndings suggest that infection by low-risk HPV results
in aberrant epithelial proliferation and differentiation.
Follow-up data were available for 6 of 9 low-risk
HPVepositive APLs. Two patients had recurrent le-
sions at the same site that were subsequently success-
fully excised. None of the low-risk HPVepositive
lesions progressed to carcinoma.
High-risk HPV was not detected in any APL or MPL
in this study. Immunohistochemical staining for p16
was used as a marker for biologically signiﬁcant in-
fection by high-risk HPV, based on studies that found
p16 overexpression to be a sensitive marker for infec-
tion by high-risk HPV and viral E7 oncoprotein expres-
sion.27 All cases of APL and MPL with a patchy pattern
of p16 staining were further studied by ISH with a
probe for HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52,
56, 58, and 66, which covered all the HPV types thatwere reported in a recent study of oral cavity squamous
cell carcinomas.31 None of the p16þ APLs and MPLs
showed high-risk HPV by ISH (see Table II), indicating
a lack of association between high-risk HPV and these
papillary lesions.
Previous studies have found an association of high-
risk HPV with a subset of severe epithelial dysplasia and
oral carcinoma. The HPV-associated severe epithelial
dysplasias have a distinctive histologic appearance, with
full-thickness loss of normal maturation and evidence
of individual cell death throughout the epithelium.23,32
MIB-1 staining showed a high proliferative index with
the majority of nuclei in the basal, parabasal, and
suprabasal layers staining positively.23 These lesions also
show diffuse, strong p16 immunostaining, owing to
inactivation of pRb by the E7 oncoprotein of high-risk
HPV. In contrast, the low-risk HPVepositive papillary
lesions in this study showed a lower proliferative index
by MIB-1 staining and patchy p16 or no p16 staining.
Thus, low-risk and high-risk groups of HPV can both
infect oral squamous epithelium, but the pathology of the
resulting lesions is different. Recent studies have sug-
gested that these differences may reﬂect the ability of the
E6 and E7 proteins of low-risk vs high-risk HPV to
interact with cell cycle regulators, particularly pRb and
p53.33
The utility of MIB-1 and p16 immunostaining as
an indirect assay for low-risk HPV was examined.
There was strong agreement between MIB-1 staining
of suprabasal epithelial cells and detection of low-risk
HPV. There was only moderate agreement between
patchy p16 staining and presence of low-risk HPV (see
Table III). Further studies of oral papillary epithelial
lesions are needed to conﬁrm that loss of localization of
MIB-1 staining to the basal and parabasal layers is a
good screening test for low-risk HPV infection.
Some of the APLs exhibited wide, elongated rete
ridges and koilocytosis in the upper spinous layers,
which raised the possibility that these were lesions of
condyloma acuminatum. However, none of the APLs
were associated with a clinical history of contact with
genital condyloma. Furthermore, we could not demon-
strate a correlation between the histologic ﬁnding of
koilocytosis and the detection of low-risk HPV by ISH.
The inconsistent presence of koilocytes in oral lesions of
condyloma makes it difﬁcult to distinguish between oral
papilloma and condyloma.1,22 The routes of trans-
mission of HPV to mucosal epithelium have not been
fully established. To avoid the implication of oral-gen-
ital contact, it is preferable to use the diagnosis of
HPV6þ/HPV11þ papillary epithelial lesion for the ISHþ
cases reported here.
Of 28 APLs, 19 were negative for low- and high-risk
HPV. These cases appeared to differ clinically from the 9
low-risk HPVepositive APLs, although the differences
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Table IV). Most notably, the HPV cases did not share
the male predominance of the HPVþ cases. Among the
11 cases with follow-up, there were 3 patients whose
APL represented an incisional biopsy of a large papillary
lesion. One patient did not undergo further surgery,
owing to poor health. The other 2 patients were subse-
quently diagnosed with verrucous carcinoma and well-
differentiated squamous cell carcinoma, respectively.
Two patients had recurrent APLs of the gingiva, and
the clinical history was consistent with proliferative
verrucous leukoplakia.34 One of these patients pro-
gressed to well-differentiated squamous cell carcinoma
at 62 months after the initial biopsy of APL. Thus, at
least some of the HPV APLs represented potentially
malignant lesions with a papillary growth pattern.
The MPLs presented clinically as extensive lesions,
in some cases involving contiguous anatomic sites, for
example, ﬂoor of mouth, edentulous mandibular ridge,
and buccal mucosa. The histologic ﬁndings were
similar to those of the APLs in that the lesion consisted
of papillary projections covered by dysplastic epithe-
lium, but the MPLs were distinguished from APLs by a
greater degree of epithelial proliferation, complex
papillary architecture, and invasion of the connective
tissue stroma (see Figure 1, G, H). Among the 10 pa-
tients with available follow-up data, none has died of
disease. MPLs appear to be low-grade squamous cell
carcinomas with a prolonged phase of exophytic, su-
perﬁcial growth. Histologic diagnosis of these lesions
as carcinoma can be problematic, because multiple bi-
opsies may be needed to conﬁrm the presence of stro-
mal invasion. We did not detect HPV in MPLs, which
agrees with recent reports of a low prevalence of HPV
in oral cavity carcinomas, including carcinomas with a
verrucous or papillary architecture.20,31,35
CONCLUSION
Our study of HPV in a spectrum of oral papillary lesions
suggests that simple squamous papillomas are rarely
HPVþ. Instead, low-risk HPV (HPV6 and -11) infection
results in papillary proliferations with clinically and/or
histologically atypical features but a benign clinical
course on follow-up. These low-risk HPVepositive
APLs may be distinguished from APLs that are poten-
tially malignant lesions, because the latter group is not
associated with HPV. MPLs are not associated with
low- or high-risk HPV.REFERENCES
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